Dermatol. praxi. 2023;17(3):126-129 | DOI: 10.36290/der.2023.024

Atopic dermatitis and ocular complications

MUDr. Nina Benáková, Ph.D.
Dermatoalergologie Immuno-Flow a Dermatovenerologická klinika 1. LF UK, Praha

Atopic comorbidities include ocular surface involvement, especially atopic keratoconjunctivitis (eyelid eczema and pruritus can be it´s signal), keratoconus, cataracta, glaucoma and retinal detachment, which can lead to severe and permanent visual impairment. Dermatologist may be the first to think of ocular comorbidities in his patients with atopic dermatitis. Early detection of ocular involvement allows for early treatment and can prevent progression and complications. The role of dermatologist is discussed in detail in the text. Interdisciplinary collaboration of dermatologist and ophtalmologist, eventually allergologist, is highly dessirable.

Keywords: ocular comorbiditis, eyelid eczema, role of dermatologists.

Accepted: October 2, 2023; Published: October 3, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Benáková N. Atopic dermatitis and ocular complications. Dermatol. praxi. 2023;17(3):126-129. doi: 10.36290/der.2023.024.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Beck KM, Seitzman GD, Yang EJ, et al. Ocular Co‑Morbidities of Atopic Dermatitis. Am J Clin Dermatol. 2019;20:797-805(Part I), 807-815 (Part II). Go to original source... Go to PubMed...
    2. Carmi E, Defossez-Tribout C, Ganry O, et al. Ocular complications of atopic dermatitis in children. Acta Derm Venereol. 2006;86:515-517. Go to original source... Go to PubMed...
    3. Hsu IH, Pflugfelder SC, Kim, SJ. Ocular complications of atopic dermatitis. Cutis. 2019;104:189-193.
    4. Pietruszyńska M, Zawadzka-Krajewska A, Duda P, et al. Ophthalmic manifestations of atopic dermatitis. Postepy Dermatol Alergol. 2020;37:174-179. Go to original source... Go to PubMed...
    5. Thyssen JP, Toft PB, Halling-Overgaard AS, et al. Incidence, prevalence, and risk of selected ocular disease in adults with atopic dermatitis. J Am Acad Dermatol. 2017;77:280-286. Go to original source... Go to PubMed...
    6. Horner ME, Abramson AK, Warren RB, et al. The spectrum of oculocutaneous disease. Part I. JAAD. 2014;795:e1-25. Go to original source... Go to PubMed...
    7. Onguchi T, Dogru M, Okada N, et al. The impact of the onset time of atopic keratoconjunctivitis on the tear function and ocular surface findings. Am J Ophthalmol. 2006;141:569-571. Go to original source... Go to PubMed...
    8. Callou TMP, Orfali RM, Sotto, MN, et al. Increase expression of filaggrin and claudin1 in the ocular surface of patients with atopic dermatitis. JEADV. 2022;36:247-254. Go to original source... Go to PubMed...
    9. Skalická P, Svozílková P, Klímová A. Konjunktivitidy. Remedia 2015;26.
    10. La Rosa M, Lionetti E, Reibaldi M, et al. Allergic cojunctivitis: comprehensive review of the literature. It J Ped. 2013;39:18. Go to original source... Go to PubMed...
    11. Hirota A, Shoji J, Inada N, et al. Evaluation of clinical efficacy and safety of prolonged treatment of vernal and atopic keratoconjunctivitis using topical tacrolimus. Cornea. 2022;41:23-30. Go to original source... Go to PubMed...
    12. Benaim D, Tétart F, Bauvin O, et al. Tacrolimus ointment in the management of atopic keratoconjunctivitis. J Fr Ophtalmol. 2019;42:435-440. Go to original source... Go to PubMed...
    13. Westland T, DE Bruin-Weller MS, Van der Lelij A. Treatment of atopic keratoconjunctivitis in patients with atopic dermatitis: is ocular application of tacrolimus an option? JEADV. 2013;27:187-189. Go to original source... Go to PubMed...
    14. Warshaw EM, Voller lM, Maibach HI, et al. Eyelid dermatitis in patients referred for patch testing: retrospective analysis of North American Contact Dermatitis Group data, 1994-2016. JAAD. 2021;84:953-964. Go to original source... Go to PubMed...
    15. Kerschenlohr K, Schaller UC, Messmer EM, et al. Das Lidekzem. Der Ophtalmologe. 2003;3:240-250. Go to original source... Go to PubMed...

    Return to the content


    Dermatology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.